08/30/2024
8:00 PM | ADMA Biologics (Subject)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
8:02 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
8:05 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
8:26 PM | ADMA Biologics (Subject)
Grossman Jerrold B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
8:22 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2024
8:00 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
8:28 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
08/14/2024
8:05 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:00 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
8:00 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/26/2024
8:05 PM | ADMA Biologics (Issuer)
Tade Brad L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:10 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
4:15 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
8:01 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
3:34 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
4:15 PM | ADMA Biologics (Subject)
Grossman Adam S (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
8:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
4:01 PM | ADMA Biologics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:06 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:35 PM | ADMA Biologics (Filer)
| Form DEFA14A | |
04/15/2024
3:40 PM | ADMA Biologics (Filer)
| Form ARS | |
04/15/2024
3:31 PM | ADMA Biologics (Filer)
| Form DEF 14A | |
04/02/2024
8:00 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
8:01 PM | ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
8:48 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:44 PM | ADMA Biologics (Subject)
Aisling Capital II LP (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
11:31 AM | ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G/A | |
03/11/2024
11:24 AM | ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
03/11/2024
11:19 AM | ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
| Form SC 13G/A | |
03/08/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
8:01 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Fong Bryant (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Biden’s Capital Gains Tax to Devastate Savings! (Ad) Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
8:00 PM | ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:15 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:21 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
8:03 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
10:47 AM | ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:50 AM | ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
| Form SC 13G | |
02/14/2024
10:37 AM | ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
| Form SC 13G | |
01/08/2024
7:00 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:30 AM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
8:00 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:30 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
3:31 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
8:00 PM | ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
8:02 PM | ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
3:45 PM | ADMA Biologics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2023
3:46 PM | ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
